FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.08), $0.11 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $184 thousand versus the consensus estimate of $240 thousand.
Cash, cash equivalents and marketable securities as of September 30, 2016 were $31.2 million, compared to $34.3 million... More

